Does PEMBROLIZUMAB Cause Exfoliative rash? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Exfoliative rash have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
30
Reports of Exfoliative rash with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
6
Deaths
18
Hospitalizations
How Dangerous Is Exfoliative rash From PEMBROLIZUMAB?
Of the 30 reports, 6 (20.0%) resulted in death, 18 (60.0%) required hospitalization, and 2 (6.7%) were considered life-threatening.
Is Exfoliative rash Listed in the Official Label?
Yes, Exfoliative rash is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Exfoliative rash?
DUPILUMAB (185)
ADALIMUMAB (121)
LENALIDOMIDE (74)
METHOTREXATE (48)
ETANERCEPT (42)
CALCIUM\ICODEXTRIN\MAGNESIUM\SODIUM\SODIUM (38)
PREDNISONE (37)
SECUKINUMAB (32)
VANCOMYCIN (32)
ABATACEPT (27)
Which PEMBROLIZUMAB Alternatives Have Lower Exfoliative rash Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G